OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans
Anu Haveri, Nina Ekström, Anna Solastie, et al.
European Journal of Immunology (2021) Vol. 51, Iss. 12, pp. 3202-3213
Open Access | Times Cited: 90

Showing 51-75 of 90 citing articles:

SARS-CoV-2-Specific Antibody (Ab) Levels and the Kinetic of Ab Decline Determine Ab Persistence Over 1 Year
Erika Garner‐Spitzer, Angelika Wagner, Michael Kundi, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 4

Impaired immunity and high attack rates caused by SARS‐CoV‐2 variants among vaccinated long‐term care facility residents
Dorothée Obach, Anna Solastie, Oona Liedes, et al.
Immunity Inflammation and Disease (2022) Vol. 10, Iss. 9
Open Access | Times Cited: 4

A Cellular Assay for Spike/ACE2 Fusion: Quantification of Fusion-Inhibitory Antibodies after COVID-19 and Vaccination
Fabien Abdul, Pascale Ribaux, Aurélie Caillon, et al.
Viruses (2022) Vol. 14, Iss. 10, pp. 2118-2118
Open Access | Times Cited: 4

Clinical course impacts early kinetics and long-term magnitude and amplitude of SARS-CoV-2 neutralizing antibodies beyond one year after infection
Edwards Pradenas, Benjamin Trinité, Víctor Urrea, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 5

Serological Survey in a university community after the fourth wave of COVID-19 in Senegal
Fatou Thiam, Abou Abdallah Malick Diouara, Clemence Stephanie Chloe Anoumba NDIAYE, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Dynamic Modeling of Antibody Repertoire Reshaping in Response to Viral Infections
Zhaobin Xu, Junxiao Xu, Hongmei Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Humoral and Innate Immunological Profile of Paediatric Recipients of Pfizer-BioNTech BNT162b2 mRNA Vaccine
Sundararaj Stanleyraj Jeremiah, Priya Das, Manu Venkatesan, et al.
Microorganisms (2024) Vol. 12, Iss. 7, pp. 1389-1389
Open Access

Proteomics of circulating extracellular vesicles reveals diverse clinical presentations of COVID-19 but fails to identify viral peptides
Melisa Gualdrón‐López, Alberto Ayllon-Hermida, Núria Cortes-Serra, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access

Serological survey in a university community after the fourth wave of COVID-19 in Senegal
Fatou Thiam, Abou Abdallah Malick Diouara, Clemence Stephanie Chloe Anoumba NDIAYE, et al.
PLoS ONE (2024) Vol. 19, Iss. 11, pp. e0298509-e0298509
Open Access

Dynamic modeling of antibody repertoire reshaping in response to viral infections
Zhaobin Xu, Qingzhi Peng, Junxiao Xu, et al.
Computers in Biology and Medicine (2024) Vol. 184, pp. 109475-109475
Closed Access

The chimera of S1 and N proteins of SARS-CoV-2: can it be a potential vaccine candidate for COVID-19?
Amresh Kumar, Amit Ladha, Ankita Choudhury, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 8, pp. 1071-1086
Closed Access | Times Cited: 3

A cellular assay for spike/ACE2 fusion: quantification of fusion-inhibitory antibodies after COVID-19 and vaccination
Fabien Abdul, Pascale Ribaux, Aurélie Caillon, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3

Development and Validation of Indirect Enzyme-Linked Immunosorbent Assays for Detecting Antibodies to SARS-CoV-2 in Cattle, Swine, and Chicken
Abhinay Gontu, Erika A. Marlin, Santhamani Ramasamy, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1358-1358
Open Access | Times Cited: 3

The Performances of Three Commercially Available Assays for the Detection of SARS-CoV-2 Antibodies at Different Time Points Following SARS-CoV-2 Infection
Heidi Syre, Marius Eduardo Brå Obreque, Ingvild Dalen, et al.
Viruses (2022) Vol. 14, Iss. 10, pp. 2196-2196
Open Access | Times Cited: 3

Anticuerpos postvacunales frente a SARS-CoV-2 en una cohorte de trabajadores de un hospital general
Susana Sabater Vidal, María Dolores Tirado-Balaguer, Raquel Soria-Martín, et al.
Archivos de Prevención de Riesgos Laborales (2022) Vol. 25, Iss. 4, pp. 358-378
Open Access | Times Cited: 3

Contrasting Effects of SARS-CoV-2 Vaccination vs. Infection on Antibody and TCR Repertoires
Jasper Braun, Elliot D. Hill, Elisa Contreras, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1

Comparative study between virus neutralisation testing and other serological methods detecting anti-SARS-CoV-2 antibodies in Europe, 2021
Ramona Mögling, Johan Reimerink, Kamelia R. Stanoeva, et al.
Journal of Virological Methods (2023) Vol. 322, pp. 114825-114825
Open Access | Times Cited: 1

Population-based study of the durability of humoral immunity after SARS-CoV-2 infection
David Peterhoff, Simon Wiegrebe, Sebastian Einhauser, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1

Weaker SARS-CoV-2 vaccine responses in nonalcoholic fatty liver disease with advanced liver fibrosis
David Hakimian, Johnny Amer, Alaa Jammal, et al.
Vaccine X (2023) Vol. 15, pp. 100359-100359
Open Access | Times Cited: 1

Immune responses of lung transplant recipients against SARS-CoV-2 and common respiratory coronaviruses: Evidence for pre-existing cross-reactive immunity
Sandhya Bansal, Timothy P. Fleming, Jesse Canez, et al.
Transplant Immunology (2023) Vol. 81, pp. 101940-101940
Closed Access | Times Cited: 1

Hybrid immunity improves the immune response after fourth Covid-19 vaccine dose in individuals with medical conditions predisposing to severe Covid-19
Nina Ekström, Tuija Leino, Aapo Juutinen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1

Serum from COVID-19 patients early in the pandemic shows limited evidence of cross-neutralization against variants of concern
Amanda J. Griffin, Kyle L. O’Donnell, Kyle Shifflett, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 2

Scroll to top